|

Sarantis: Sales Down, Margins Up; Earnings Guidance Reiterated

Q2 showed a flattish top-line (+1% yoy) whereas EBITDA (+25% yoy) and EBIT (+25% yoy) grew impressively, pushing margins up +300bps yoy. SAR lowered its FY 2025 sales guidance by 2.5% but reiterated its earnings targets. No change in 2026-2028.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   

Similar Posts